PATENT CLAIM ANALYSIS

Application Number: 15878291
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "456000"]

Abstract:
The invention provides compounds of formula I: and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers, Alzheimer's disease, and conditions associated with demyelination.

Claim (Index 12):
The compound of  claim 1  that is selected from the group consisting of: or a salt thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.25806
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15878297', '14344867', '15550230', '15112111', '15878289']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7901206245325103
- 35 USC 102 Novelty (BERT): 0.5650526506292358
- Combined Prediction Score: 0.7676138271421828
- Mean Citation Score: 390.457968
- Max Citation Score: 452.13422
- Similarity Product: 343.01526635750537

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test